Skip to main content
OpenTrials

Clinical trial condition

Leiomyosarcoma

Explore clinical trials studying Leiomyosarcoma. Study availability and eligibility vary by location and protocol.

56 public trials 19 recruiting studies
Refine in advanced search Browse all conditions

Leiomyosarcoma trial results

Recruiting

STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas

NCT06975293

Conditions
Dedifferentiated Liposarcoma, Leiomyosarcoma, Liposarcoma, +7 more
Locations
  • University of California, San Francisco San Francisco, California, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Northwell Health Cancer Institute Lake Success, New York, United States
  • MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Recruiting

Localized Leiomyosarcoma Biomarker Protocol

NCT04925089

Conditions
Leiomyosarcoma, Neoplasms, Neoplasms by Histologic Type, +3 more
Locations
  • University of Michigan Ann Arbor, Michigan, United States
  • Mayo Clinic Rochester, Minnesota, United States
  • Vanderbilt University Medical Center Nashville, Tennessee, United States
View Trial Details
Recruiting

Metastatic Leiomyosarcoma Biomarker Protocol

NCT05653388

Conditions
Leiomyosarcoma, Neoplasms, Neoplasms by Histologic Type, +3 more
Locations
  • Sarcoma Oncology Research Center Santa Monica, California, United States
  • University of Miami Miami, Florida, United States
  • Dana- Farber Boston, Massachusetts, United States
  • University of Michigan Cancer Center Ann Arbor, Michigan, United States
View Trial Details
Recruiting

A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors

NCT06789172

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +49 more
Locations
  • Precision NextGen Oncology and Research Center Beverly Hills, California, United States
  • Sarcoma Oncology Center Santa Monica, California, United States
  • MD Anderson Cancer Center Houston, Texas, United States
  • Chris O'Brien Lifehouse Sydney, New South Wales, Australia
View Trial Details
Recruiting

A Study of Ivonescimab in People With Leiomyosarcoma

NCT07516925

Conditions
Leiomyosarcoma, Neoplasms, Neoplasms by Histologic Type, +3 more
Locations
  • Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities) Commack, New York, United States
View Trial Details
Recruiting

Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma

NCT04031677

Conditions
Leiomyosarcoma, Liposarcoma, Neoplasms, +6 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • UCI Health-Chao Family Comp CC and Ambulatory Care Irvine, California, United States
View all 169 locations
View Trial Details
Recruiting

Agnostic Therapy in Rare Solid Tumors

NCT06638931

Conditions
Adenocarcinoma, Adenoid Cystic Carcinoma, Adenoma, +131 more
Locations
  • Hospital São Carlos Fortaleza, Ceará, Brazil
  • Hospital São Rafael Salvador, Estado de Bahia, Brazil
  • Hospital Santa Cruz Curitiba, Paraná, Brazil
  • IDOR Recife Recife, Pernambuco, Brazil
View Trial Details
Recruiting

Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS)

NCT03016819

Conditions
Alveolar Soft Part Sarcoma, Leiomyosarcoma, Neoplasms, +9 more
Locations
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • University of California Los Angeles Los Angeles, California, United States
  • Sarcoma Oncology Center Santa Monica, California, United States
  • Stanford Medicine Cancer Institute Stanford, California, United States
View all 24 locations
View Trial Details

Related conditions